China Streptokinase Market Research Report 2018

Publisher Name :
Date: 19-Feb-2018
No. of pages: 108
Inquire Before Buying

The global Streptokinase market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Streptokinase development status and future trend in China, focuses on top players in China, also splits Streptokinase by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- SAMARTH PHARMA

- Biocon

- Kee Pharma

- Dabur

- Biosena

- Wanbang Biopharma

- Qingdao GD Biotechnology Pharmaceutical

- Aristo Pharmaceuticals

- Neiss Labs

- Ahaan Healthcare Pvt Ltd. (AHPL)

- Biofactor

- TTK HealthCare

- Incepta Pharmaceuticals Limited

- Cadila

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- type 1

- type 2

On the basis of the end users/application, this report covers

- Myocardial Infarction (MI)

- Deep vein thrombosis

- Pulmonary embolism

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

China Streptokinase Market Research Report 2018

Table of Contents
China Streptokinase Market Research Report 2017
1 Streptokinase Overview
1.1 Product Overview and Scope of Streptokinase
1.2 Classification of Streptokinase by Product Category
1.2.1 China Streptokinase Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Streptokinase Sales (K Units) Market Share by Type in 2016
1.2.3 type 1
1.2.4 type 2
1.3 China Streptokinase Market by Application/End Users
1.3.1 China Streptokinase Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 Myocardial Infarction (MI)
1.3.3 Deep vein thrombosis
1.3.4 Pulmonary embolism
1.3.5 Others
1.4 China Streptokinase Market by Region
1.4.1 China Streptokinase Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Streptokinase Status and Prospect (2012-2022)
1.4.3 East China Streptokinase Status and Prospect (2012-2022)
1.4.4 Southwest China Streptokinase Status and Prospect (2012-2022)
1.4.5 Northeast China Streptokinase Status and Prospect (2012-2022)
1.4.6 North China Streptokinase Status and Prospect (2012-2022)
1.4.7 Central China Streptokinase Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Streptokinase (2012-2022)
1.5.1 China Streptokinase Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Streptokinase Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Streptokinase Market Competition by Players/Manufacturers
2.1 China Streptokinase Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Streptokinase Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Streptokinase Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Streptokinase Market Competitive Situation and Trends
2.4.1 China Streptokinase Market Concentration Rate
2.4.2 China Streptokinase Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Streptokinase Manufacturing Base Distribution, Sales Area, Product Types
3 China Streptokinase Sales and Revenue by Region (2012-2017)
3.1 China Streptokinase Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Streptokinase Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Streptokinase Price (USD/Unit) by Regions (2012-2017)
4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
4.1 China Streptokinase Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Streptokinase Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Streptokinase Price (USD/Unit) by Type (2012-2017)
4.4 China Streptokinase Sales Growth Rate (%) by Type (2012-2017)
5 China "&B1&" Sales by Application (2012-2017)"
5.1 China Streptokinase Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Streptokinase Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Streptokinase Players/Suppliers Profiles and Sales Data
6.1 SAMARTH PHARMA
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Streptokinase Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 SAMARTH PHARMA Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Biocon
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Streptokinase Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Biocon Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Kee Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Streptokinase Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Kee Pharma Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 Dabur
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Streptokinase Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Dabur Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biosena
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Streptokinase Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biosena Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Wanbang Biopharma
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Streptokinase Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Wanbang Biopharma Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Qingdao GD Biotechnology Pharmaceutical
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Streptokinase Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Aristo Pharmaceuticals
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Streptokinase Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Aristo Pharmaceuticals Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Neiss Labs
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Streptokinase Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Neiss Labs Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Ahaan Healthcare Pvt Ltd. (AHPL)
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Streptokinase Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
6.11 Biofactor
6.12 TTK HealthCare
6.13 Incepta Pharmaceuticals Limited
6.14 Cadila
7 Streptokinase Manufacturing Cost Analysis
7.1 Streptokinase Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Streptokinase
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Streptokinase Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Streptokinase Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Streptokinase Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Streptokinase Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Streptokinase Sales (K Units) Forecast by Type (2017-2022)
11.3 China Streptokinase Sales (K Units) Forecast by Application (2017-2022)
11.4 China Streptokinase Sales (K Units) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Streptokinase Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Streptokinase Sales (K Units) by Application (2016-2022)
Figure Product Picture of Streptokinase
Table China Streptokinase Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Streptokinase Sales Volume Market Share by Types in 2016
Figure type 1 Product Picture
Figure type 2 Product Picture
Figure China Streptokinase Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Streptokinase by Application in 2016
Figure Myocardial Infarction (MI) Examples
Table Key Downstream Customer in Myocardial Infarction (MI)
Figure Deep vein thrombosis Examples
Table Key Downstream Customer in Deep vein thrombosis
Figure Pulmonary embolism Examples
Table Key Downstream Customer in Pulmonary embolism
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Streptokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Streptokinase Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Streptokinase Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Streptokinase Sales of Key Players/Manufacturers (2012-2017)
Table China Streptokinase Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Streptokinase Sales Share (%) by Players/Manufacturers
Figure 2017 China Streptokinase Sales Share (%) by Players/Manufacturers
Table China Streptokinase Revenue by Players/Manufacturers (2012-2017)
Table China Streptokinase Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Streptokinase Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Streptokinase Revenue Market Share (%) by Players/Manufacturers
Table China Market Streptokinase Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Streptokinase Average Price of Key Players/Manufacturers in 2016
Figure China Streptokinase Market Share of Top 3 Players/Manufacturers
Figure China Streptokinase Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Streptokinase Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Streptokinase Product Category
Table China Streptokinase Sales (K Units) by Regions (2012-2017)
Table China Streptokinase Sales Share (%) by Regions (2012-2017)
Figure China Streptokinase Sales Share (%) by Regions (2012-2017)
Figure China Streptokinase Sales Market Share (%) by Regions in 2016
Table China Streptokinase Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Streptokinase Revenue Market Share (%) by Regions (2012-2017)
Figure China Streptokinase Revenue Market Share (%) by Regions (2012-2017)
Figure China Streptokinase Revenue Market Share (%) by Regions in 2016
Table China Streptokinase Price (USD/Unit) by Regions (2012-2017)
Table China Streptokinase Sales (K Units) by Type (2012-2017)
Table China Streptokinase Sales Share (%) by Type (2012-2017)
Figure China Streptokinase Sales Share (%) by Type (2012-2017)
Figure China Streptokinase Sales Market Share (%) by Type in 2016
Table China Streptokinase Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Streptokinase Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Streptokinase by Type (2012-2017)
Figure Revenue Market Share of Streptokinase by Type in 2016
Table China Streptokinase Price (USD/Unit) by Types (2012-2017)
Figure China Streptokinase Sales Growth Rate (%) by Type (2012-2017)
Table China Streptokinase Sales (K Units) by Applications (2012-2017)
Table China Streptokinase Sales Market Share (%) by Applications (2012-2017)
Figure China Streptokinase Sales Market Share (%) by Application (2012-2017)
Figure China Streptokinase Sales Market Share (%) by Application in 2016
Table China Streptokinase Sales Growth Rate (%) by Application (2012-2017)
Figure China Streptokinase Sales Growth Rate (%) by Application (2012-2017)
Table SAMARTH PHARMA Streptokinase Basic Information List
Table SAMARTH PHARMA Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure SAMARTH PHARMA Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure SAMARTH PHARMA Streptokinase Sales Market Share (%) in China (2012-2017)
Figure SAMARTH PHARMA Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Biocon Streptokinase Basic Information List
Table Biocon Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biocon Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Biocon Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Biocon Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Kee Pharma Streptokinase Basic Information List
Table Kee Pharma Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Kee Pharma Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Kee Pharma Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Kee Pharma Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Dabur Streptokinase Basic Information List
Table Dabur Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Dabur Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Dabur Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Dabur Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Biosena Streptokinase Basic Information List
Table Biosena Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Biosena Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Biosena Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Biosena Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Wanbang Biopharma Streptokinase Basic Information List
Table Wanbang Biopharma Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Wanbang Biopharma Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Wanbang Biopharma Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Wanbang Biopharma Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Qingdao GD Biotechnology Pharmaceutical Streptokinase Basic Information List
Table Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Qingdao GD Biotechnology Pharmaceutical Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Aristo Pharmaceuticals Streptokinase Basic Information List
Table Aristo Pharmaceuticals Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Aristo Pharmaceuticals Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Aristo Pharmaceuticals Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Aristo Pharmaceuticals Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Neiss Labs Streptokinase Basic Information List
Table Neiss Labs Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Neiss Labs Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Neiss Labs Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Neiss Labs Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Basic Information List
Table Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales Market Share (%) in China (2012-2017)
Figure Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Revenue Market Share (%) in China (2012-2017)
Table Biofactor Streptokinase Basic Information List
Table TTK HealthCare Streptokinase Basic Information List
Table Incepta Pharmaceuticals Limited Streptokinase Basic Information List
Table Cadila Streptokinase Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Streptokinase
Figure Manufacturing Process Analysis of Streptokinase
Figure Streptokinase Industrial Chain Analysis
Table Raw Materials Sources of Streptokinase Major Players/Manufacturers in 2016
Table Major Buyers of Streptokinase
Table Distributors/Traders List
Figure China Streptokinase Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Streptokinase Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Streptokinase Price (USD/Unit) Trend Forecast (2017-2022)
Table China Streptokinase Sales (K Units) Forecast by Type (2017-2022)
Figure China Streptokinase Sales (K Units) Forecast by Type (2017-2022)
Figure China Streptokinase Sales Volume Market Share Forecast by Type in 2022
Table China Streptokinase Sales (K Units) Forecast by Application (2017-2022)
Figure China Streptokinase Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Streptokinase Sales Volume Market Share Forecast by Application in 2022
Table China Streptokinase Sales (K Units) Forecast by Regions (2017-2022)
Table China Streptokinase Sales Volume Share Forecast by Regions (2017-2022)
Figure China Streptokinase Sales Volume Share Forecast by Regions (2017-2022)
Figure China Streptokinase Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Blood Plasma Products Market Size, Status and Forecast 2018-2025
    Published: 19-Sep-2018        Price: US 3900 Onwards        Pages: 99
    This report focuses on the global Blood Plasma Products status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Plasma Products development in United States, Europe and China. Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a componen......
  • Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 62
    Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 Summary According to the recently published report 'Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H2 2018'; Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) pipeline Target constitutes close to 9 molecules. Transmembrane Prolyl 4 Hydroxylase (Hypoxia Ind......
  • CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 60
    CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2018 Summary CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) pipeline Target constitutes close to 18 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/ins......
  • Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 128
    Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) pipeline Target constitutes close to 27 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the universities/institutes. The latest report Histone Deacetylase 2 - P......
  • Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 150
    Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary According to the recently published report 'Histone Deacetylase 1 - Pipeline Review, H2 2018'; Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) pipeline Target constitutes close to 29 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the universities/institutes. Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 i......
  • Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 72
    Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2018 Summary Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Myostatin also known as growth differentiation factor 8 or GDF-8 is a myokine a protein produced and released by myocytes. This protein is part of the transforming growth factor beta (TGFß) superfamily. Myostatin is found almost in muscles used for movement, where it is active both before and after birth. This p......
  • Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 32
    Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018 Summary Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Cathepsin B (CatB) is an enzymatic protein belonging to the peptidase. It promotes hydrolysis of proteins with broad specificity for peptide bonds. It cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates. In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-......
  • Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 73
    Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018 Summary According to the recently published report 'Hepatocyte Growth Factor - Pipeline Review, H2 2018'; Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 14 molecules. Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Hepatocyte growth factor (HGF) is a paracrine cellular growth an......
  • Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 53
    Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018 Summary Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Glial -derived neurotrophic factor is a member of the cysteine-knot superfamily of growth factors. It promotes the survival and differentiation of dopaminergic neurons and was able to prevent apoptosis of motor neurons. The mature form of the protein is a lig......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs